⚠️DEA Registration Revocation
The Drug Enforcement Administration's order revokes Massoud Amini, M.D.'s registration to handle controlled substances, citing the revocation of his California medical license. The decision underscores the necessity for practitioners to maintain state licensing to comply with federal regulations, affecting their ability to operate lawfully in the medical field.
Learn More📋Comments Notice on Information Collection by HHS and CMS
The Centers for Medicare & Medicaid Services (CMS) is announcing an opportunity for the public to comment on CMS' intention to collect information from the public. Under the Paperwork Reduction Act of 1995 (PRA), federal agencies are required to publish notice in the Federal Register concerning each proposed collection of information, including each proposed extension or reinstatement of an existing collection of information, and to allow a second opportunity for public comment on the notice. Interested persons are invited to send comments regarding the burden estimate or any other aspect of this collection of information, including the necessity and utility of the proposed information collection for the proper performance of the agency's functions, the accuracy of the estimated burden, ways to enhance the quality, utility, and clarity of the information to be collected, and the use of automated collection techniques or other forms of information technology to minimize the information collection burden.
Learn More⚔️Executive Order 14183
Executive Order 14183 emphasizes the importance of maintaining high standards for military readiness and cohesion, revoking previous policies that accommodate radical gender ideologies in the Armed Forces. The order mandates updates to medical and mental health standards to ensure service members meet the rigorous requirements necessary for effective military service.
Learn More🚫Executive Order on Funding for Gender Transition Procedures in Minors
Executive Order 14187 aims to protect children from medical interventions related to gender transition, prohibiting federal funding and promoting a policy shift in pediatric healthcare. It mandates a review of existing guidelines and outlines actions for various government departments to enforce these provisions and prioritize children's health.
Learn More💊DEA Notice
Medi-Physics Inc. DBA GE Healthcare has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to SUPPLEMENTARY INFORMATION listed below for further drug information.
Learn More⚖️DOJ Seeks Compliance on Electronic Prescriptions for Controlled Substances
The Department of Justice (DOJ), Drug Enforcement Administration (DEA), will be submitting the following information collection request to the Office of Management and Budget (OMB) for review and approval in accordance with the Paperwork Reduction Act of 1995.
Learn More🏠Emergency Price Relief Measures for American Families and Businesses
The memorandum outlines actions to provide emergency price relief for American families, targeting regulatory barriers contributing to high living costs. It emphasizes the need to reduce unnecessary regulatory burdens on housing, healthcare, and energy sectors, aiming to restore purchasing power and improve the quality of life for Americans.
Learn More✈️Class E Airspace Amendment for Kenansville, NC Effective April 2025
This action amends Class E airspace extending upward from 700 feet above the surface for Kenansville, NC, by adding airspace for ECU Health Duplin Heliport. Controlled airspace is necessary for the safety and management of instrument flight rules (IFR) operations at this airport.
Learn More🏥FDA Workshop on Optimizing Pregnancy Registries
The Food and Drug Administration (FDA, the Agency, or we) is announcing the following public workshop entitled "Optimizing Pregnancy Registries." The purpose of the public workshop is to discuss challenges in designing and implementing pregnancy registries and to consider innovative approaches to improve the design and conduct of pregnancy registries to inform the safety of drug and biological products during pregnancy. This public workshop is being held in collaboration with the University of Maryland Center of Excellence in Regulatory Science and Innovation program.
Learn More